Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.

A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely to ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

"People who suffer from sickle cell have challenges that I don't believe we all know," Philpart said. "Sometimes it gets lost ...

Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the ...